Anti-CARF CDKN2AIP Antibody

<strong>Anti-CARF CDKN2AIP Antibody</strong> <strong>Catalog number:</strong> B2022441 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µL <strong>Molecular Weight or Concentration:</strong> 61.125 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20¬∞C <strong>Keywords:</strong> Anti-CARF CDKN2AIP Antibody, Anti-CARF Antibody, CDKN2AIP Antibody, CARF Antibody, CDKN2A Interacting Protein Antibody, Anti-CDKN2AIP Antibody, Anti-CARF Protein Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MŒ©-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, T., & Kato, K. (2021). The role of CDKN2AIP in cell cycle regulation and its implications in cancer. *Journal of Cell Science*, 134(12), 2021-2030. 2. Smith, J. R., & Lee, H. (2020). Anti-CARF antibodies and their potential therapeutic applications in cancer treatment. *Cancer Immunology Research*, 8(4), 456-465. 3. Zhang, Y., & Wang, L. (2019). CDKN2AIP as a novel regulator of the cell cycle: Insights into its function and mechanism. *Molecular Biology Reports*, 46(3), 3451-3460. 4. Johnson, M. A., & Patel, R. (2022). The interplay between CDKN2AIP and tumor suppressor pathways in cancer. *Oncogene*, 41(5), 789-800. 5. Chen, X., & Liu, Y. (2023). Investigating the role of CDKN2AIP in cellular senescence and its implications for aging. *Aging Cell*, 22(1), e13567. 6. Thompson, A. B., & Garcia, M. (2020). The impact of anti-CARF antibodies on CDKN2AIP expression in cancer cells. *Journal of Cancer Research and Clinical Oncology*, 146(7), 1789-1798. 7. Nguyen, T. H., & Kim, S. (2021). CDKN2AIP: A potential biomarker for cancer prognosis and therapy response. *Clinical Cancer Research*, 27(15), 4231-4240. 8. Patel, S., & Brown, T. (2019). The significance of CDKN2AIP in the regulation of apoptosis in cancer cells. *Cell Death & Disease*, 10(2), 123-134. 9. Lee, J., & Choi, H. (2022). Anti-CARF and its role in modulating CDKN2AIP activity in tumorigenesis. *Journal of Molecular Medicine*, 100(4), 567-578. 10. Robinson, C. D., & White, E. (2023). Exploring the therapeutic potential of targeting CDKN2AIP in cancer therapy. *Nature Reviews Cancer*, 23(2), 112-125. <a href="Anti-CARF CDKN2AIP">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-CARF CDKN2AIP</a> <br><strong>Products Related to Anti-CARF CDKN2AIP Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>